Quiron Group, Barcelona (Spain)

Academic/Hospital

Also known as: Institute of Breast Cancer, Quirón Group, Barcelona (Spain) | International Breast Cancer Center (IBCC), Quiron Group, Barcelona (Spain)

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Jul 31, 2021

Last known activity

May 31, 2024

Timeline

No events for the selected filters.

Drugs by trial phase (8 distinct, 3 trials)

Phase 2 (8 own, 0 via acquisition)

eribulin
paclitaxel
hyaluronidase (human recombinant)
trastuzumab
pertuzumab
fam-trastuzumab deruxtecan-nxki
balixafortide
men1611

Recent trials (4)

NCT06172127Overall official - principal investigatorPhase 2May 31, 2024
NCT06172127OfficialPhase 2May 31, 2024
NCT05810870Overall official - principal investigatorPhase 2May 24, 2023
NCT04826016Overall official - principal investigatorPhase 1/Phase 2Jul 31, 2021

Details

Last known activity: May 31, 2024